Pathy 2 - Ferro

Pathway 2-Ferro™

Specially Formulated for Those Following Jane McLelland

Supports cell clearing, proliferation, and cell-cycle modulation.

ONCO-ADJUNCT™ Pathway 2-Ferro™ delivers two LPS™ bioactive polyphenols plus frankincense using shellfish-free chondroitin as the protein scaffold.

1. ChonCur™ Chondroitin-Curcumin supports cell clearing by activating the p53, NRF2, and NFkB pathways.
2. ChonQuer™ LPS™ Chondroitin-Quercetin also supports the p53 pathway, and additionally activates TLR4 and histamine related pathways in the body, supporting cell proliferation and cell-cycle modulation.*
3. Frankincense (Boswellia) supports cell proliferation and synergizes the activity of our LPS™ ingredients.*

What’s Different about Pathway 2-Ferro™?

ONCO-ADJUNCT™ PATHWAY 2-Ferro

The main difference between Pathway 2™ and Pathway 2-Ferro™ is that they use different protein scaffolds.

Pathway 2™ uses brown rice protein as the scaffold, whereas Pathway 2-Ferro™ uses shellfish-free chondroitin.

Pathway 2-Ferro™ typically appeals to those who follow Jane McLelland’s recommendation to reduce overall cysteine in the diet.

The Ferro serving size is 1 capsule twice a day, compared to 3 capsules twice a day with Pathway 2™.

Taken together with Pathway 1™, Pathway 3™, and Pathway 4™, Pathway 2-Ferro™ helps modulate the function of your cellular pathways to promote cellular activity.

IMPORTANT WARNING:

This product should only be used under medical supervision. Do not use without consulting your doctor if you are taking any blood thinners.

We advise you to consult with your healthcare practitioners regarding any questions or concerns about using these products, and their appropriate dosing.

Do not take this product on the day before, day of, or day after a chemotherapy treatment, as it may diminish the effectiveness of chemo cytotoxic interventions.

The following interactions with curcumin have been discussed in the medical literature:

Chemo therapeutic suppression was potentially found with curcumin and camptothecin, mechlorethamine, and doxorubicin. Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Res. 2002;62(13):3868-3875. (PubMed)

Curcumin affects the FXa node in the thrombin pathway. Any anti-coagulant therapy that acts directly on thrombin should be avoided (Hirudin, Argatroban, Bivalirudin, Dabigatran). Any Indirect or direct FXa inhibitors should be discussed with your doctor.